|
({[({4-[(1E)-2,6-dimethylhepta-1,5-dien-1-yl]phenyl}methoxy)methyl](hydroxy)phosphoryl}methyl)phosphonic acid
|
E608739-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
({[({4-[(1E)-2,6-dimethylhepta-1,5-dien-1-yl]phenyl}methoxy)methyl](hydroxy)phosphoryl}methyl)phosphonic acid
|
E608739-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3E)-4-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-oxobut-3-enoic acid
|
E608729-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3E)-4-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-oxobut-3-enoic acid
|
E608729-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E,2S)-N-(3-bromophenyl)-N'-cyano-2-methyl-4-{5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperazine-1-carboximidamide
|
E608725-5mg
|
Moligand™ |
1116571-01-7 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E,2S)-N-(3-bromophenyl)-N'-cyano-2-methyl-4-{5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperazine-1-carboximidamide
|
E608725-25mg
|
Moligand™ |
1116571-01-7 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2E)-4-(dimethylamino)-1-[6-({5-methyl-4-[1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)-1,2,3,4-tetrahydroisoquinolin-2-yl]but-2-en-1-one
|
E608690-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2E)-4-(dimethylamino)-1-[6-({5-methyl-4-[1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)-1,2,3,4-tetrahydroisoquinolin-2-yl]but-2-en-1-one
|
E608690-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-({[(3-{[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)methyl]carbamoyl}(hydroxy)amino)-2-methylpropanoate
|
E608688-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-({[(3-{[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenyl)methyl]carbamoyl}(hydroxy)amino)-2-methylpropanoate
|
E608688-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
{[(3-{[(3E)-4,8-dimethylnona-3,7-dien-1-yl](methyl)amino}propoxy)(hydroxy)phosphoryl]oxy}phosphonic acid
|
E608680-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
{[(3-{[(3E)-4,8-dimethylnona-3,7-dien-1-yl](methyl)amino}propoxy)(hydroxy)phosphoryl]oxy}phosphonic acid
|
E608680-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[2-ethyl-3-oxamoyl-1-(phenylmethyl)benzo[g]indol-4-yl]oxyacetic acid
|
E608677-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[2-ethyl-3-oxamoyl-1-(phenylmethyl)benzo[g]indol-4-yl]oxyacetic acid
|
E608677-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ethyl 4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzoate
|
E608669-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
ethyl 4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzoate
|
E608669-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[(E)-2-phenylethenyl]pyrimidin-2-amine
|
E608665-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[(E)-2-phenylethenyl]pyrimidin-2-amine
|
E608665-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[(3E)-3-(5-carbamimidoyl-1,3-dihydrobenzimidazol-2-ylidene)-5-(3-carbamoylphenyl)-4-oxocyclohexa-1,5-dien-1-yl]butanedioic acid
|
E608663-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[(3E)-3-(5-carbamimidoyl-1,3-dihydrobenzimidazol-2-ylidene)-5-(3-carbamoylphenyl)-4-oxocyclohexa-1,5-dien-1-yl]butanedioic acid
|
E608663-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E)-3-[3-chloro-4-[3-(3,5-dimethyl-1-adamantyl)-4-hydroxyphenyl]phenyl]prop-2-enoic acid
|
E608638-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E)-3-[3-chloro-4-[3-(3,5-dimethyl-1-adamantyl)-4-hydroxyphenyl]phenyl]prop-2-enoic acid
|
E608638-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
α-Emtbl
|
E607541-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
α-Emtbl
|
E607541-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |